Cell biology cloud computing market seen reaching $7.9B by 2030

By AI, Created 5:15 PM UTC, May 18, 2026, /AGP/ – The Business Research Company says the cell biology cloud computing market will nearly double by 2030 as researchers lean more on cloud platforms for data-heavy analysis and simulation. The forecast points to growing demand from personalized medicine, AI-driven tools and biotech collaboration.

Why it matters: - Cell biology research is becoming more data-intensive, and cloud computing is increasingly the infrastructure that makes large-scale analysis and simulation possible. - The forecast signals rising demand from biotech, pharmaceuticals and precision medicine workflows that need scalable computing power. - The market’s expected growth to $7.89 billion by 2030 suggests cloud-based research tools are moving from support function to core research capability.

What happened: - The Business Research Company released its Cell Biology Cloud Computing Market Report 2026 on May 14, 2026. - The report projects the market will rise from $3.98 billion in 2025 to $4.56 billion in 2026. - The report forecasts the market will reach about $7.9 billion by 2030. - The report puts the 2025-2030 CAGR at 14.7%.

The details: - Cell biology cloud computing uses cloud platforms and computational infrastructure to analyze biological datasets, run cellular simulations and store research results securely. - The report says growth has been driven by genomic and proteomic research, greater use of local computational resources, demand for advanced cellular simulations, higher investment in academic and research institutions, and broader pharmaceutical R&D. - The report says future growth will be supported by hybrid cloud models, AI-driven analysis platforms, large-scale simulation and modeling, cloud-based biotechnology and pharmaceutical projects, and more collaborative research platforms. - A free sample of the report is available here. - The full report is available here. - The report also points readers to related reports on online microtransactions, bioinformatics platforms and commercial quantum computing solutions.

Between the lines: - Personalized and precision medicine are becoming a major demand driver because they depend on detailed genetic, molecular, environmental and lifestyle data. - In February 2024, the Personalized Medicine Coalition reported that the US Food and Drug Administration approved 16 new personalized treatments for rare diseases, up from six approvals in 2022. - That jump suggests the clinical pipeline for precision medicine is widening, which raises the need for cloud tools that can handle complex biological datasets. - North America held the largest market share in 2025, reflecting its research infrastructure and investment levels. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

What’s next: - The market is expected to keep expanding as research teams shift toward hybrid cloud setups and AI-assisted analysis. - Biotech and pharmaceutical users are likely to drive more demand for scalable simulation, modeling and collaboration tools. - Regional competition may intensify as Asia-Pacific growth accelerates against North America’s established lead.

The bottom line: - Cell biology cloud computing is moving into a bigger role in life-sciences research, with precision medicine and AI-heavy workflows pushing the market toward a projected $7.9 billion by 2030.